C63.9 vs Z12.83

C63.9 (Malignant neoplasm of male genital organ, unspecified) compared with Z12.83 (Encounter for screening for malignant neoplasm of skin), from the official CMS tabular data. Z12.83 is the personal-history/screening code for the active disease C63.9 names. MedCoder-derived

Relationship

Review

Condition lifecycle relationship

Z12.83

Encounter for screening for malignant neoplasm of skin

↔

C63.9

Malignant neoplasm of male genital organ, unspecified

Personal-history or screening code versus the active disease.

Active disease for this site (skin)

A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code for the same site.

Source: CMS Table of Neoplasms (site match derived from the code title)

Can these codes be reported together?

History or screening versus active disease. Z12.83 is the personal-history or screening code for the active disease C63.9 names.

Site match derived from the code’s own title against the CMS/CDC Table of Neoplasms. A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code.

Side by side

	C63.9Malignant neoplasm of male genital organ, unspecified	Z12.83Encounter for screening for malignant neoplasm of skin
Billing status	Billable	Billable
Classification	C00-D49 — Neoplasms (C00-D49)	Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)
Definition	Malignant neoplasm of male genital organ, unspecified is a billable ICD-10-CM diagnosis code (C63.9).	Encounter for screening for malignant neoplasm of skin is a billable ICD-10-CM diagnosis code (Z12.83).
Includes	malignant neoplasm of skin of male genital organs Malignant neoplasm of male genitourinary tract NOS	—
Use additional code	—	code to identify any family history of malignant neoplasm (Z80.-)

Edit this comparison Check a whole claim

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources